ReviewCurrent oncology reports2021
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building.
Review in Current oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 18 citations in OpenAlex.
- Co-Design and Pilot Testing of a Nurse-Led GP-Supported Self-Management Intervention for Breast Cancer Survivors with Cardiovascular Diseases: A Study Protocol.Nursing reports (Pavia, Italy) · 2026Article
- Cardiovascular risk in cancer patients: initial experience from a cardio-oncology clinic in Mexico.Archivos de cardiologia de Mexico · 2025Article
- Community Engagement to Advance Equitable Cardio-Oncology Care: A Call to Action:JACC. CardioOncology · 2024Review
- Using the consolidated framework for implementation research (CFIR) to guide implementation of cardio-oncology services.Learning health systems · 2024Article
- Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.American heart journal plus : cardiology research and practice · 2024Article
- Characteristics of patients with newly diagnosed hematological malignancies referred for echocardiography.Frontiers in oncology · 2024Article
- Risk and Management of Patients with Cancer and Heart Disease.Cardiology and therapy · 2023Review
- Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER-Medicare study.European journal of cancer (Oxford, England : 1990) · 2023Article
- Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations.Frontiers in oncology · 2023Review
- Social Media and Cardiovascular Health: Implications for Women.Current atherosclerosis reports · 2022Review
- Practical Approaches to Build and Sustain a Cardio-Oncology Clinic.Journal of cardiovascular development and disease · 2022Review
- Artificial intelligence applications in cardio-oncology: Leveraging high dimensional cardiovascular data.Frontiers in cardiovascular medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 11 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis study aims to assess the current state of cardio-oncology in reference to advocacy efforts, access to care, and perspective of stakeholders in their ability to provide patient care as well as development of "across the aisle" synergy among cardiologists and oncologists and academic and non-academic centers in various worldwide locations. RECENT
findingsDuring the last decade, there has been a significant and diverse growth in cardio-oncology. We reviewed the experience from cardiologists and oncologists across different healthcare systems, the global trends, the role of collaborative networks, and the importance of advocacy efforts. Cardio-oncology will continue to grow, but there is an unmet need to increase awareness, improve education, and expand access to care to larger segments of the cancer population in order to have a more significant impact on their health. The growing collaboration through professional societies and collaborative networks provides an opportunity to advance the cardiovascular care of cancer patients to meet the projected needs in a growing and more diverse population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.